Current clinical trials, like the PROLIPSY study for prostate cancer, breast cancer, non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and pancreatic cancer (60), indicate the potential use of CTCs for early cancer detection
What Patients Need to Know Side effects: Similar to other GLP-1 drugsmostly nausea, vomiting, or digestive upset
It has been demonstrated that endogenous GLP-1 could help maintain a normal glycemic level acting through GLP-1 receptors (37)
To make sense of them, it helps to separate the drug itself from the nutritional and metabolic changes that follow a sharp drop in appetite
Statements describing research applications refer to academic and preclinical literature and do not constitute claims of efficacy or safety for any application